| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Cerdulatinib
|
1369761-01-2 |
CERDULATINIB 盐酸盐
|
CERDULATINIB 盐酸盐
|
C20H28ClN7O3S |
481.99942 | |
|
CEP-18770
|
847499-27-8 |
CEP-1877
|
CS-252;CEP-18770;CEP 18770;CEP18770;[(1R)-1-[[(2S,3R)-3-羟基-1-氧代-2-[[(6-苯基-2-吡啶基)羰基]氨基]丁基]氨基]-3-甲基丁基]硼酸;德兰佐米;地兰佐米
|
413.27512 | ||
|
CAY10505
|
1218777-13-9 |
CAY155
|
(5E)-5-[[5-(4-氟苯基)-2-呋喃基]亚甲基]-2,4-噻唑烷二酮
|
C14H8FNO3S |
289.281623 | |
|
Cathepsin Inhibitor 1
|
225120-65-0 |
Cathepsin Inhibitor 1
|
N-[(1S)-1-[(3-氯苯基)甲基]-2-[(氰基甲基)氨基]-2-氧代乙基]-3-叔丁基-1-甲基-1H-吡唑-5-甲酰胺;组织蛋白酶抑制剂1
|
C20H24ClN5O2 |
401.88986 | |
|
Butein
|
487-52-5 |
紫铆因
|
紫铆因;紫铆查尔酮;紫铆花素;紫铆因标准品;2',3,4,4'-四羟基查尔酮;2-[(E)-2-(2-氨基苯基)乙烯基]-5-甲基-8-羟基喹啉;紫铆查耳酮;2-[(E)-2-(2-氨基苯基)乙烯基]-5-甲基-喹啉-8-醇
|
C15H12O5 |
272.25 | 207-659-5 |
|
Buclizine Hydrochloride
|
129-74-8 |
盐酸安其敏
|
盐酸安其敏;盐酸布可立嗪;布克立嗪/1-(对-叔丁苄基)-4-(对-氯代二苯甲基)哌嗪;盐酸安其敏,盐酸布可立嗪
|
C28H33N2Cl.HCl |
469.48896 | 204-962-4 |
|
BS-181 Hydrochloride
|
1397219-81-6 |
BS181
|
BS181;BS 181;CS-979;BS-181 盐酸盐
|
C22H33ClN6 |
416.99062 | |
|
BRL-15572
|
193611-72-2 |
BRL15572 盐酸盐
|
3-(4-(3-chlorophenyl)piperazin-1-yl)-1,1-diphenylpropan-2-ol dihydrochloride;BRL 15572 HYDROCHLORIDE;3-[4-(4-CHLOROPHENYL)PIPERAZIN-1-YL]-1,1-DIPHENYL-2-PROPANOL HCL;3-[4-(4-CHLOROPHENYL)PIPERAZIN-1-YL]-1,1-DIPHENYL-2-PROPANOL HYDROCHLORIDE;BRL15572HCl;BRL-15572 (dihydrochloride);BRL-15572 dihydrochloride
(BRL15572;4-(3-Chlorophenyl)-alpha-(diphenylmethyl)-1-piperazineethanol dihydrochloride
|
C25H28Cl2N2O |
443.41 | |
|
Brivanib (BMS-540215)
|
649735-46-6 |
酪氨酸激酶抑制剂
|
1-[[4-[(4-氟-2-甲基-1H-吲哚-5-基)氧基]-5-甲基吡咯并[2,1-f][1,2,4]三嗪-6-基]氧基]-2-丙醇;BMS540215;BMS 540215;CS-75;布立尼布杂质;1-[[4-[(4-氟-2-甲基-1H-吲哚-5-基)氧基]-5-甲基吡咯并[2,1-F][1,2,4]三嗪-6-基]氧基]-2-丙醇;布立尼布;布立尼布、BMS-540215;酪氨酸激酶抑制剂
|
C19H19FN4O3 |
370.382 | |
|
BRD73954
|
1440209-96-0 |
BRD73954
|
CS-1777;BRD73954;BRD-73954;BRD 73954;N1-羟基-N3-(2-苯基乙基)-1,3-苯二甲酰胺
|
C16H16N2O3 |
284.30984 | |
|
BMS-536924
|
468740-43-4 |
胰岛素样生长因子-1 受体拮抗剂
|
CS-469;BMS 536924;BMS536924;胰岛素样生长因子-1 受体拮抗剂
|
C25H26ClN5O3 |
479.95864 | |
|
BMS-345541
|
445430-58-0 |
BMS-345541
|
CS-1910;N-(1,8-二甲基咪唑并[1,2-A]喹喔啉-4-基)-1,2-乙二胺;BMS-345541 游离;N1-(1,2-A]喹噁啉-4-基)-1,2-乙二胺;BMS-345541 (游离碱);BMS345541;BMS 345541;IKK INHIBITOR III
|
C14H17N5 |
255.31828 | -0 |
|
BLZ945
|
953769-46-5 |
BLZ945
|
CS-1735;BLZ-945;BLZ 945
|
C20H22N4O3S |
398.47868 | |
|
Bismuth Subcitrate Potassium
|
880149-29-1 |
枸橼酸铋钾
|
2-羟基-1,2,3-丙烷三羧酸铋钾盐
|
C12H10BiK5O14+2 |
782.67 | |
|
Birinapant (TL32711)
|
1260251-31-7 |
BIRINAPANT
|
(2S,2'S)-N,N'-[(6,6'-DIFLUORO[2,2'-BI-1H-INDOLE]-3,3'-DIYL)BIS[METHYLENE[(2R,4S)-4-HYDROXY-2,1-PYRRO;TL-32711 ≥98%;TL-32711;TL32711;TL 32711. BIRINAPANT;CS-801;比瑞那帕
|
C42H56F2N8O6 |
806.940846 | |
|
Biperiden Hydrochloride
|
1235-82-1 |
盐酸比哌立登
|
盐酸比哌立登;1,3-双(2-乙酰-3-羟基苯氧基)-2-丙醇;盐酸比哌立登;NSC 170950;NSC 84989;1-(5-双环[2.2.1]庚-2-烯基)-1-苯基-3-(1-哌啶基)丙-1-醇盐酸盐;双环哌丙醇盐酸盐;BIPERIDEN 盐酸盐;盐酸比哌立登( 1,3-双(2-乙酰-3-羟基苯氧基)-3-丙醇);抗胆碱能药物
|
C21H29NO.HCl |
347.922 | 214-976-2 |
|
BI-D1870
|
501437-28-1 |
BI-D187
|
BID1870;BI-D 1870;2-[(3,5-二氟-4-羟基苯基)氨基]-7,8-二氢-5,7-二甲基-8-(3-甲基丁基)-6(5H)-蝶啶酮
|
C19H23F2N5O2 |
391.42 | |
|
Besifloxacin Hydrochloride
|
405165-61-9 |
盐酸贝西沙星
|
盐酸贝西沙星(BESIFLOXACIN HYDROCHLORIDE);盐酸贝西沙星中间体;CS-781;(R)-7-(3-氨基氮杂环庚烷-1-基)-8-氯-1-环丙基-6-氟-4-氧代-1,4-二氢喹啉-3-甲酸 盐酸盐;BESIFL氧杂CIN 盐酸盐;贝西沙星盐酸盐;盐酸贝西沙星
|
C19H21ClFN3O3.HCl |
430.305 | 696-612-6 |
|
Bekanamycin
|
4696-76-8 |
卡那霉素 B
|
卡那霉素B;卡那霉素 B>99%
|
C18H37N5O10 |
483.51 | 225-170-5 |
|
Bazedoxifene Hydrochloride
|
198480-56-7 |
盐酸巴多昔芬
|
盐酸巴多昔芬;CS-1416
|
C30H35ClN2O3 |
507.0635 |
药智官方微信
药智官方微博
